Last reviewed · How we verify
NCT05816460: SACS
The Sleepio After Cancer Study
NA trial testing Digital Cognitive Behavioural Therapy for Insomnia (dCBT-I) in Insomnia in 308 participants. Status unknown.
10 June 2024
Quick facts
| Lead sponsor | University College Dublin |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 308 |
| Start date | 22 May 2023 |
| Primary completion | 10 June 2024 |
| Estimated completion | 10 June 2024 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- Digital Cognitive Behavioural Therapy for Insomnia (dCBT-I)
- Sleep Hygiene Education (SHE)
Conditions studied
Sponsor
University College Dublin
Who can join
18 and older, female only, with Insomnia or Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will recruit women over the age of 18 with a current or prior cancer diagnosis who have clinical insomnia. This study will examine the efficacy of digital cognitive behavioural therapy for insomnia (dCBT-I) compared to sleep hygiene education.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Sleepio After Cancer (SAC) study. Digital cognitive behavioural therapy for insomnia (dCBT-I) in women cancer patients - Trial protocol of a randomised controlled trial.
Treacy T, O'Meara Y, Galligan MC, Henry AL, et al · · 2024 · cited 2× · PMID 37741507 · DOI 10.1016/j.cct.2023.107337
Verify or expand the search:
- PubMed search for NCT05816460
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Insomnia
Currently open trials in the same condition.
- NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
- NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
- NCT07071324 — CF Wellness Program · NA · recruiting
- NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
- NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting
Other University College Dublin trials
Trials by the same sponsor.
- NCT07434804 — Exploring the Feasibility of Using Virtual Reality as an Educational Tool in Chronic Pain Rehabilitation · NA · not yet recruiting
- NCT07386483 — Strategic Timing of Resistance Training to Guard Against Antipsychotic-Induced Metabolic Syndrome · NA · not yet recruiting
- NCT07417228 — The Impact of Concurrent Training on Women Experiencing Symptoms of Menopause · NA · recruiting
- NCT07189221 — Implementation and Evaluation of Bump2Baby and Me+ Programme for Gestational Diabetes Mellitus in Routine Maternity Care · NA · not yet recruiting
- NCT07009964 — An Exploratory Feasibility Study · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05816460 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University College Dublin
- Last refreshed: 23 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05816460.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing